Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Deeksha Bhandari21 March 2026 9:00 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
T2D, Obesity and Heart Failure: Breaking the Pathophysiologic Triangle Dr. Kamal Kant Kohli19 March 2026 10:15 AM ISTIndia's diabetes burden has risen markedly, with 101 million individuals living with diabetes. The clinical burden is compounded by heart failure...
The 1st Tooth Crosstalk | Episode 3 | Oral Hygiene in Babies - What Early Interventions Matter? Dr. Bhumika Maikhuri18 March 2026 10:45 AM ISTIn this video, we are joined by two leading pediatricians - Dr Nitha Jose and Dr Neethu John, along with Dr Aswanth K.P., dentist, all from Kerala....
T2D and CKD Risk: Can Weight Loss Alter Kidney Outcomes? Dr. Kamal Kant Kohli16 March 2026 11:03 AM ISTType 2 diabetes mellitus (T2DM) represents a mounting global health crisis. India, home to 17.78% of the world's population, ranks second globally...
The Adiposity-Inflammation Axis in T2D: Implications for Heart and Kidney Dr. Kamal Kant Kohli13 March 2026 10:57 AM ISTIndia is home to nearly 90 million people with T2DM , with an estimated 39.4 million remaining undiagnosed. Recent estimates from India indicate...
Management of Chemotherapy-Induced Anemia (CIA) in an Immuno-oncotherapy-Treated Cancer Patient - Dr Debashis Chatterjee Dr Debashis Chatterjee12 March 2026 11:23 AM ISTChemotherapy-induced anemia, gallbladder cancer, and immunotherapy management are important clinical challenges in oncology practice. In this video,...
Managing Pediatric Drug-Induced Dyspepsia with H2 Receptor Antagonists (H2RAs): Indian Paediatricians' Perspectives Dr. Bhumika Maikhuri12 March 2026 10:30 AM ISTDrugs are identified as a frequent cause of new-onset dyspeptic symptoms, like upper abdominal pain, early sense of satiety, epigastric discomfort...
MASLD in T2D: Why Weight Loss Is More Than Cosmetic? Dr. Kamal Kant Kohli10 March 2026 10:26 AM ISTIndia's diabetes burden is escalating rapidly, with 101 million adults currently living with T2DM (ICMR-INDIAB Study)1. Compounding this crisis,...
From Psoriasis to Psoriatic Arthritis: Strategies for Early Risk Modification Dr. Bhumika Maikhuri9 March 2026 11:15 AM ISTKey Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, including obesity, severe...
Beyond Glycaemia- Weight Reduction Is the New Additional Therapeutic Endpoint in T2D Dr. Kamal Kant Kohli7 March 2026 10:59 AM ISTIndia bears a disproportionate share of the global diabetes burden, with 89.8 million adults living with T2DM against a worldwide estimate of 589...
PRO-ACT Study Shows Better Outcomes with Minoxidil PRCT for Androgenetic Alopecia Dr. Bhumika Maikhuri7 March 2026 10:00 AM ISTA recent clinical study has highlighted the potential of a novel Minoxidil formulation integrated with bioactive peptides for the management of...
Presence to Precision: Moving beyond Omnichannel - Gurpinder Singh Gurpinder Singh6 March 2026 3:17 PM ISTThe pharma industry's legacy is based on constant innovation, particularly in the R&D space. Undoubtedly, science has made strides in treating...
